Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The University of Texas Health Science Center, Houston
Masonic Cancer Center, University of Minnesota
Lumos Pharma
Children's Oncology Group
Children's Oncology Group
University Hospital, Bonn
Children's Oncology Group
Dana-Farber Cancer Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Taiwan University Hospital
Duke University
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Mayo Clinic